15019AST
Astec® CHIROBIOTIC® V2 Chiral (5 μm) HPLC Columns
L × I.D. 15 cm × 2.1 mm, HPLC Column
Sinônimo(s):
Chiral Stationary Phase Column V2
About This Item
Produtos recomendados
product name
Astec® CHIROBIOTIC® V2 Chiral HPLC Column, 5 μm particle size, L × I.D. 15 cm × 2.1 mm
Materiais
stainless steel column
Agency
suitable for USP L88
descrição
HPLC column
linha de produto
Astec®
embalagem
pkg of 1 ea
fabricante/nome comercial
Astec®
Parâmetros
0-45 °C temperature
241 bar pressure (3500 psi)
técnica(s)
HPLC: suitable
LC/MS: suitable
C × D.I.
15 cm × 2.1 mm
matriz
High-purity silica gel particle platform
fully porous particle
Grupo ativo da matriz
vancomycin phase
tamanho de partícula
5 μm
tamanho de poro
200 Å
operating pH range
3.5-7.0
técnica de separação
chiral
Procurando produtos similares? Visita Guia de comparação de produtos
Descrição geral
- Bonded phase: Vancomycin
- Operating pH range: 3.5 - 7.0
- Particle diameter: 5, 10 or 16 μm
- Pore size: 100 Å (CHIROBIOTIC® V) or 200 Å (CHIROBIOTIC® V2)
CHIROBIOTIC FAQs
CHIROBIOTIC Reference Bibliography
Chiral Product Literature
Aplicação
- Development and validation of an UFLC-MS/MS method for enantioselectivity determination of d,l-thero-methylphenidate, d,l-thero-ethylphenidate and d,l-thero-ritalinic acid in rat plasma and its application to pharmacokinetic study.: This study highlights the application of the Astec® CHIROBIOTIC® V2 chiral HPLC column in the pharmacokinetic assessment of chiral drugs, demonstrating its utility in accurate and efficient chiral separation for analytical chemistry in pharmacological research (Zhang et al., 2016).
- New high-performance liquid chromatography method for the determination of (R)-warfarin and (S)-warfarin using chiral separation on a glycopeptide-based stationary phase.: This paper describes a method using the Astec® CHIROBIOTIC® V2 chiral HPLC column to differentiate between the enantiomers of warfarin, showcasing its critical role in therapeutic drug monitoring and clinical pharmacology, which is essential for ensuring patient safety and efficacy in treatments (Malakova et al., 2009).
Informações legais
Choose from one of the most recent versions:
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica